Clinical Data's PGx Revenues Rise in Q3, Loss up on Rx R&D Costs | GenomeWeb

NEW YORK (GenomeWeb News) – Clinical Data today reported a 4 percent decline in its third-quarter 2008 revenues and a more than five-fold increase in its net loss on higher R&D costs associated with a phase III drug study.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.